Dawid Wolak

Dawid Wolak

Auto-generated profile, based on publicly available information

Dawid Wolak

Faculty of Medical Science in Katowice , Medical University of Silesia , Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
PDF file
MWMarek Wojczyk
Marek Wojczyk
PRPaulina Rutecka
Paulina Rutecka
DWDawid Wolak
Dawid Wolak
ZZZuzanna ZięBa
Zuzanna ZięBa
DZDorota Zatłoka
Dorota Zatłoka
KWKatarzyna Wójtowicz
Katarzyna Wójtowicz
Introduction: To reduce the incidence of influenza, healthcare workers and medical students are recommended to receive annual seasonal vaccination. This study aimed to investigate the behavior of students regarding their willingness to be vaccinated against influenza and the attitudes influencing their approval or disapproval of influenza vaccination. Materials and Methods: This cross-sectional study was designed as an online survey among students of the Medical University of Silesia (MUS) of all years and specialties, as MUS is the largest medical college in Poland. A total of 302 students participated in the study and completed an online questionnaire. The collected data were analyzed using descriptive and analytical statistics. The significance of the differences was tested using the chi-square test. Results: The percentage of students who received influenza vaccinations in the past was 42.1%, and in the current influenza season (Autumn 2022) was 33.4%. The level of vaccination differed significantly depending on the study program (p < 0.001). An important variable affecting the decision to vaccinate was participation in clinical classes. Among the students taking practical classes, 59.4% were vaccinated. Most respondents had a positive opinion about influenza vaccination (98%). Belief in the effectiveness of vaccination (35.6%) was the main reason for vaccination against influenza, as indicated by the respondents. The main reason for not being vaccinated was a lack of fear of influenza infection (22.9%). Conclusions: The results obtained in this study indicate the need to introduce changes in the field of broader education regarding the effectiveness of vaccinations in reducing the number of influenza virus infections among medical students.

1 January 2025 in Dermatologic Therapy
Verified
Journal Article
Open access
PRPaulina Rutecka
Paulina Rutecka
AFAleksandra Fratczak
Aleksandra Fratczak
DWDawid Wolak
Dawid Wolak
WKWiktor Kruczek
Wiktor Kruczek
KPKarina Polak
Karina Polak
BBBeata Bergler-Czop
Beata Bergler-Czop
Background: Hailey–Hailey disease (familial benign chronic pemphigus) is a rare autosomal dominant genodermatosis caused by ATP2C1 gene mutations, leading to defective calcium‐dependent ATPase. The function of this protein is to regulate calcium sequestration in the Golgi apparatus. While the mutation leads to impaired desmosome function, causing acantholysis of the suprabasal epidermis in the skin. Clinically, it presents with vesicles, erosions, fissures and weeping plaques, primarily in intertriginous areas. Symptoms worsen with heat, sweat, friction, and trauma, while treatment options remain limited. Objectives: The aim of this systematic review was to review the available literature to assess the efficacy and safety of botulinum toxin as a therapeutic option for the treatment of Hailey–Hailey disease. Methods: A literature review was conducted in Embase and MEDLINE using keywords like “Hailey–Hailey disease,” “pemphigus,” and “botulin toxin.” The search followed PRISMA guidelines, incorporating EMTREE and MESH terms. Inclusion criteria covered original trials, case reports, and case series in English until July 2025. Of 28 identified studies, 21 were included after further manual review. Results: Twenty‐one articles involving 68 patients described the use of botulinum toxin in HHD. Most patients achieved significant improvement and partial or complete remission of skin symptoms after injection or reinjection of botulinum toxin. Only one patient showed no improvement in target lesions. Combined botulinum toxin, photodynamic therapy, and dapsone yielded superior improvement with PDT + BoNT‐A showing better outcomes than BoNT‐A alone. No side effects were observed. Conclusions: Botulinum toxin appears to be a promising therapeutic alternative in HHD with a very good tolerability, both as a complementary treatment and as an adjuvant to other forms of therapy, such as PDT. Larger studies are required to confirm its efficacy, long‐term effects, and also to establish the optimal doses and number of botulinum toxin injections resulting in a standardized treatment regimen.